BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9371520)

  • 21. Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.
    Rhind N; Furnari B; Russell P
    Genes Dev; 1997 Feb; 11(4):504-11. PubMed ID: 9042863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staurosporine- and radiation-induced G2-phase cell cycle blocks are equally released by caffeine.
    Crompton NE; Hain J; Jaussi R; Burkart W
    Radiat Res; 1993 Sep; 135(3):372-9. PubMed ID: 8378530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staurosporine overrides checkpoints for mitotic onset in BHK cells.
    Tam SW; Schlegel R
    Cell Growth Differ; 1992 Nov; 3(11):811-7. PubMed ID: 1467308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.
    Tsao YP; D'Arpa P; Liu LF
    Cancer Res; 1992 Apr; 52(7):1823-9. PubMed ID: 1312900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide.
    Lock RB
    Cancer Res; 1992 Apr; 52(7):1817-22. PubMed ID: 1551112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S-phase feedback control in budding yeast independent of tyrosine phosphorylation of p34cdc28.
    Sorger PK; Murray AW
    Nature; 1992 Jan; 355(6358):365-8. PubMed ID: 1731250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
    Kawamoto H; Koizumi H; Uchikoshi T
    Am J Pathol; 1997 Jan; 150(1):15-23. PubMed ID: 9006317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed cyclin B1 expression during the G2 arrest following DNA damage.
    Maity A; Hwang A; Janss A; Phillips P; McKenna WG; Muschel RJ
    Oncogene; 1996 Oct; 13(8):1647-57. PubMed ID: 8895510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of p34cdc2 protein kinase activity by phosphorylation and cyclin binding.
    Nigg EA; Gallant P; Krek W
    Ciba Found Symp; 1992; 170():72-84; discussion 84-96. PubMed ID: 1483352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genesis and evolution of high-ploidy tumour cells evaluated by means of the proliferation markers p34(cdc2), cyclin B1, PCNA and 3[H]-thymidine.
    Baroja A; de la Hoz C; Alvarez A; Ispizua A; Bilbao J; de Gandarias JM
    Cell Prolif; 1996 Feb; 29(2):89-100. PubMed ID: 8630339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.
    Downes CS; Clarke DJ; Mullinger AM; Giménez-Abián JF; Creighton AM; Johnson RT
    Nature; 1994 Dec; 372(6505):467-70. PubMed ID: 7984241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts.
    Clarke PR; Hoffmann I; Draetta G; Karsenti E
    Mol Biol Cell; 1993 Apr; 4(4):397-411. PubMed ID: 8389619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
    Gu Y; Rosenblatt J; Morgan DO
    EMBO J; 1992 Nov; 11(11):3995-4005. PubMed ID: 1396589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A.
    Roberge M; Tudan C; Hung SM; Harder KW; Jirik FR; Anderson H
    Cancer Res; 1994 Dec; 54(23):6115-21. PubMed ID: 7954457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of p34cdc2 coincident with taxol-induced apoptosis.
    Donaldson KL; Goolsby GL; Kiener PA; Wahl AF
    Cell Growth Differ; 1994 Oct; 5(10):1041-50. PubMed ID: 7848905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.
    Russell KJ; Wiens LW; Demers GW; Galloway DA; Plon SE; Groudine M
    Cancer Res; 1995 Apr; 55(8):1639-42. PubMed ID: 7712467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents.
    Hofmann J; O'Connor PM; Jackman J; Schubert C; Ueberall F; Kohn KW; Grunicke H
    Biochem Biophys Res Commun; 1994 Mar; 199(2):937-43. PubMed ID: 8135843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein tyrosine phosphatase 1B undergoes mitosis-specific phosphorylation on serine.
    Schievella AR; Paige LA; Johnson KA; Hill DE; Erikson RL
    Cell Growth Differ; 1993 Apr; 4(4):239-46. PubMed ID: 8494789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage.
    Poon RY; Jiang W; Toyoshima H; Hunter T
    J Biol Chem; 1996 May; 271(22):13283-91. PubMed ID: 8662825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Okadaic acid overrides the S-phase check point and accelerates progression of G2-phase to induce premature mitosis in HeLa cells.
    Ghosh S; Schroeter D; Paweletz N
    Exp Cell Res; 1996 Aug; 227(1):165-9. PubMed ID: 8806464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.